Wolters Kluwer to acquire Lexi-Comp
PHILADELPHIA — Market research firm Wolters Kluwer Health will acquire drug information provider Lexi-Comp, Wolters Kluwer said Wednesday. Financial terms of the deal were not disclosed.
Wolters Kluwer already had a relationship with Lexi-Comp through the former’s UpToDate business, which provides electronic clinical information through the Internet and mobile devices to more than 400,000 clinicians and other users. Lexi-Comp, based in Cleveland, provides drug information and medical reference content to more than 1,500 hospitals around the world and publishes drug monographs on more than 1,700 products.
Wolters Kluwer said the acquisition would strengthen its position in the clinical decision support and point-of-care segments and provide customers with more robust drug information and clinical content, allowing pharmacists, nurses and physicians to use an extended suite of mobile capabilities and online platforms.
Price Chopper brings APhA’s Project Impact: Diabetes initiative to stores
SCHENECTADY, N.Y. — Northeast supermarket chain Price Chopper will expand several of its health-and-wellness programs to combat diabetes as part of its participation in the American Pharmacists Association Foundation’s Project Impact: Diabetes initiative, the chain said.
The multiyear initiative, which the APhA Foundation announced last month, is designed to improve care for people across the country affected by diabetes. For its part, Price Chopper will expand its Diabetes AdvantEdge HealthyU Diabetes Education program and the NuVal nutrition ranking system under a partnership with the Capital District Physician’s Health Plan. Of the 25 companies nationwide participating, Price Chopper, which operates 128 stores in New York, Pennsylvania and New England, is the only one in New York.
“Diabetes care is a priority at Price Chopper,” Price Chopper VP pharmacy Vincent Mainella said. “We recognize that our stores are a bona fide destination for patients seeking the prescriptions, accessories, fresh foods and nutritional information needed to help them manage their diabetes.”
Prime Therapeutics notes lower hospitalization rate among adherent diabetics
ST. PAUL, Minn. — Diabetes patients who adhere to their medication therapies have a significantly lower risk of hospitalization, according to a new study scheduled for presentation this week at the Academy of Managed Care Pharmacy’s 23rd annual meeting and showcase in Minneapolis.
The study, conducted by pharmacy benefit manager Prime Therapeutics using data from more than 15,000 patients, found that medication adherence among diabetes patients cut the risk of hospitalization by 31%, compared with patients who were not compliant.
“Our research found adherent individuals had $1,010 lower medical costs during the year,” Prime director for clinical outcomes assessment Patrick Gleason said. “Besides the medical cost savings, patients that adhere to their medications are likely to have improved health and increased quality of life. Yet in this study, we found one-quarter of patients do not stick to their diabetes medication, so the medical community must find ways to increase adherence for those most at risk.”